Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Jun 2022 for NanoVibronix, Inc., €23k.
Filing timeline
BuySaleChristopher M. Fashek
Insider track record
Disclosed buys
3
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-7.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Christopher M. Fashek: trading record in brief
Christopher M. Fashek is a declared insider at 2 companies (board member); the most frequent names are ENvue Medical, Inc. and Kinetic Concepts Inc /TX/. We count 6 filings; the first trade dates from 1 April 2006 and the latest from 15 June 2022.
Market trades split into 3 purchases (€75k) and 1 sale (€3.6M). Netting one side against the other leaves €3.5M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. In 2022 alone, the filings show 2 purchases and no sales.
In size, the median ticket on the buying side is €23k.
The record was last updated on 17 June 2022 with an open-market purchase (€23k) in ENvue Medical, Inc. Typically, a trade is published a median of 7 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher M. Fashek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
40,000 shares@ US$0.5957100.0% of flowCommon StockSEC:0001493152-22-017169:0
Canonical exit: 13 Sept 2022 (T+90)
25,000 shares@ US$2.000.0000% mcap66.4% of flowCommon StockSEC:0001493152-22-017164:0
Canonical exit: 18 Feb 2020 (T+90)
2 of 2 declarations
